Natural history and physiological determinants of changes in glucose tolerance in a non-diabetic population: The RISC Study

Diabetologia

Volumn 54, Issue 6, 2011, Pages 1507-1516

  Ferrannini, E ^a   Natali, A ^a   Muscelli, E ^a   Nilsson, P M ^b   Golay, A ^c   Laakso, M ^d   Beck Nielsen, H ^e   Mari, A ^f  

^a UNIVERSITY OF PISA   (Italy)

^b LUND UNIVERSITY   (Sweden)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^d UNIVERSITY OF EASTERN FINLAND   (Finland)

^e ODENSE UNIVERSITY HOSPITAL   (Denmark)

^f CNR   (Italy)

Author keywords

Beta cell function; Diabetes; Dysglycaemia progression; Glucose tolerance; Insulin resistance

Indexed keywords

GLUCAGON;

ADULT; AGE; ARTICLE; CELL FUNCTION; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENDER; GLUCAGON BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE; HUMAN; HUMAN EXPERIMENT; INSULIN RELEASE; INSULIN SENSITIVITY; LIFESTYLE; MALE; MATHEMATICAL MODEL; NORMAL HUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PHENOTYPE; PHYSICAL ACTIVITY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; WAIST HIP RATIO; CARDIOVASCULAR DISEASE; EUROPE; FOLLOW UP; GLUCOSE INTOLERANCE; INCIDENCE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR; THEORETICAL MODEL;

ADULT; CARDIOVASCULAR DISEASES; EUROPE; FEMALE; FOLLOW-UP STUDIES; GLUCOSE CLAMP TECHNIQUE; GLUCOSE INTOLERANCE; HUMANS; INCIDENCE; INSULIN-SECRETING CELLS; MALE; MIDDLE AGED; MODELS, THEORETICAL; PHENOTYPE; RISK FACTORS;

EID: 80052547130     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-011-2112-x     Document Type: Article

References (32)

1. Yudkin JS, Alberti KG, McLarty DG, Swai AB (1990) Impaired glucose tolerance. BMJ 301:397-402
2. Ferrannini E, Massari M, Nannipieri M, Natali A, Ridaura RL, Gonzales-Villalpando C (2009) Plasma glucose levels as predictors of diabetes: the Mexico City Diabetes Study. Diabetologia 52:818-824
3. Ferrannini E, Nannipieri M, Williams K, Gonzales C, Haffner SM, Stern MP (2004) Mode of onset of type 2 diabetes from normal or impaired glucose tolerance. Diabetes 53:160-165 (Pubitemid 38044710)
4. Mason CC, Hanson RL, Knowler WC (2007) Progression to type 2 diabetes characterized by moderate then rapid glucose increases. Diabetes 56:2054-2061 (Pubitemid 47195817)
5. Tabák AG, Jokela M, Akbaraly TN, Brunner EJ, Kivimäki M, Witte DR (2009) Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet 373:2215-2221
6. Keen H, Jarrett RJ, McCartney P (1982) The ten-year follow-up of the Bedford Survey (1962-1972): glucose tolerance and diabetes. Diabetologia 22:73-78 (Pubitemid 12162119)
7. Alvarsson M, Hilding A, Östenson C-G (2009) Factors determining normalization of glucose intolerance in middle-aged Swedish men and women: a 8-10-year follow-up. Diabet Med 26:345-353
8. Perreault L, Kahn SE, Christophi CA, Knowler WC, Hamman RF, Diabetes Prevention Program Research Group (2009) Regression from pre-diabetes to normal glucose regulation in the diabetes prevention program. Diabetes Care 32:1583-1588
9. Warram JH, Martin BC, Krolewski AS, Soeldner JS, Kahn CR (1990) Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. Ann Intern Med 113:909-915
10. Martin BC, Warram JH, Krolewski AS, Bergman RN, Soeldner JS, Kahn CR (1992) Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet 340:925-929
11. Lillioja S, Mott DM, Spraul M et al (1993) Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus: prospective studies of Pima Indians. N Engl J Med 329:1988-1992 (Pubitemid 24015042)
12. Weyer C, Bogardus C, Mott DM, Pratley RE (1999) The natural history of insulin secretory dysfunction and insulin resistance in the development of type 2 diabetes mellitus: a longitudinal study in Pima Indians. J Clin Invest 104:787-794 (Pubitemid 29536364)
13. Haffner SM, Howard G, Mayer E et al (1997) Insulin sensitivity and acute insulin response in African-Americans, non-Hispanic whites, and Hispanics with NIDDM: the Insulin Resistance Atherosclerosis Study. Diabetes 46:63-69 (Pubitemid 27009951)
14. Hanley AJ, Wagenknecht LE, Norris JM et al (2009) Insulin resistance, beta cell dysfunction and visceral adiposity as predictors of incident diabetes: the Insulin Resistance Atherosclerosis Study (IRAS) Family study. Diabetologia 52:2079-2086
15. Xiang AH, Kjos SL, Takayanagi M, Trigo E, Buchanan TA (2010) Detailed physiological characterization of the development of type 2 diabetes in Hispanic women with prior gestational diabetes. Diabetes 59:2625-2630
16. Hills SA, Balkau B, Coppack SW, EGIR-RISC Study Group et al (2004) The EGIR-RISC STUDY (The European Group for the Study of Insulin Resistance: Relationship Between Insulin Sensitivity and Cardiovascular Disease Risk): I. Methodology and objectives. Diabetologia 47:566-570 (Pubitemid 38491256)
17. Ferrannini E, Balkau B, Coppack SW, Investigators RISC et al (2007) Insulin resistance, insulin response, and obesity as indicators of metabolic risk. J Clin Endocrinol Metab 92:2885-2892
18. Balkau B, Mhamdi L, Oppert JM, EGIR-RISC Study Group et al (2008) Physical activity and insulin sensitivity: the RISC study. Diabetes 57:2613-2618
19. Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ (2001) A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diab Care 24:539-548 (Pubitemid 32198427)
20. Mari A, Schmitz O, Gastaldelli A, Oestergaard T, Nyholm B, Ferrannini E (2002) Meal and oral glucose tests for assessment of beta-cell function: modeling analysis in normal subjects. Am J Physiol Endocrinol Metab 283:E1159-E1166 (Pubitemid 35340621)
21. Van Cauter E, Mestrez F, Sturis J, Polonsky KS (1992) Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 41:368-377
22. Mari A, Tura A, Natali A, Investigators RISC et al (2010) Impaired beta cell glucose sensitivity rather than inadequate compensation for insulin resistance is the dominant defect in glucose intolerance. Diabetologia 53:749-756
23. Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC (1994) Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 17:961-969 (Pubitemid 24268605)
24. Colditz GA, Willett WC, Rotnitzky A, Manson JE (1995) Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 122:481-486
25. Kahn SE, Hull RL, Utzschneider KM (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444:840-846 (Pubitemid 46024990)
26. Hajer GR, van Haeften TW, Visseren FL (2008) Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J 29:2959-2971
27. Utzschneider KM, Prigeon RL, Carr DB et al (2006) Impact of differences in fasting glucose and glucose tolerance on the hyperbolic relationship between insulin sensitivity and insulin responses. Diabetes Care 29:356-362 (Pubitemid 44106518)
28. Després JP, Lemieux I (2006) Abdominal obesity and metabolic syndrome. Nature 444:881-887
29. Rader DJ (2007) Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus. Am J Med 120(3 Suppl 1):S12-S18
30. DeFronzo RA, Simonson D, Ferrannini E (1982) Hepatic and peripheral insulin resistance: a common feature of insulinin-dependent and insulin-dependent diabetes. Diabetologia 23:313-319 (Pubitemid 12020666)
31. Matsuda M, Defronzo RA, Glass L et al (2002) Glucagon dose-response curve for hepatic glucose production and glucose disposal in type 2 diabetic patients and normal individuals. Metabolism 51:1111-1119
32. Ferrannini E, Muscelli E, Natali A, RISC Investigators et al (2007) Association of fasting glucagon and proinsulin concentrations with insulin resistance. Diabetologia 50:2342-2347 (Pubitemid 47512409)